Displaying 51 - 60 of 121
Alternative Name: Pericoital LNG gel
Active Status: No
User: Female
Mode: Yes
Delivery Type: Vaginal Gel
Developer: Population Council
Project Stage: Phase I
Active Status: Yes
Mode: Yes
Delivery Type: Injectable
Developer: WHO HRP, CONRAD, NICHD
Project Stage: Phase I
Alternative Name: Twirla; AG200-15; Levonorgestrel + ethinyl estradiol patch
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Transdermal
Developer: Agile Therapeutics
Project Stage: Phase III
Alternative Name: Levonorgestrel Gastric Resident Dosage Form, Levonorgestrel Gastric Retentive Dosage Form
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Oral
Developer: Lyndra Therapeutics, Massachusetts Institute of Technology
Project Stage: Pre-clinical
Alternative Name: Levonorgestrel (LNG) Intracervical Device (ICD)
Active Status: No
User: Female
Mode: Yes
Delivery Type: Vaginal, Other
Developer: University of Helsinki, Population Council
Project Stage: Phase I
Alternative Name: Levonorgestrel (LNG)-only patch; AG890
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Transdermal
Developer: Agile Therapeutics
Project Stage: Phase II
Alternative Name: One-year LNG Single Rod Implant
Active Status: No
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: CONRAD, FEI Technologies
Project Stage: Phase I
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable, Subdermal
Developer: Orbis Biosciences
Project Stage: Pre-clinical
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: FHI 360
Project Stage: Phase I
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: Merck
Project Stage: Phase II
Pages
